Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-02-23
2000-08-15
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, 514416, 514417, 514418, 548468, 548472, 548473, 548480, 548490, 548950, A61K 3140, A61K 31405, C07D20914, C07D20948, C07D40306
Patent
active
061037524
ABSTRACT:
Compounds of formula (I) ##STR1## wherein R and R.sup.1 are hydrogen, C.sub.1-4 alkyl or are linked to form a ring,
REFERENCES:
patent: 4988703 (1991-01-01), Norbeck et al.
patent: 5037845 (1991-08-01), Oxford
Avram et al Chem. Ber., 1957, 1425 1.3-Disubstituierte Cyclobutanderivate.
Bradley, et al., "Proposals for the Classification and Nomenclature of Functional Receptors for 5-Hydroxytryptamine," Neuropharmacology, vol. 25, No. 6, pp. 563-576 (supplied by Applicants as an attachment to Paper No. 7), 1986.
Foster Christopher James
Glen Robert Charles
Martin Graeme Richard
Selwood David Lawrence
Glaxo Wellcome Inc.
Oswecki Jane C.
Richter Johann
LandOfFree
Therapeutic heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2007351